|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 99.55 SAR | -0.10% |
|
-1.34% | +4.79% |
| 02-02 | Morgan Stanley Begins Nahdi Medical's Coverage at Overweight | MT |
| 01-29 | Citi Upgrades Nahdi Medical to Buy | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 5.44% | 5.7% | 15.85x | 4.88x | 1.4x | 8.37x | 15.4x | 3.45B | ||
| -.--% | -.--% | 33.89x | 2.84x | 1.96x | 31.7x | 35.82x | 25.08B | ||
| -.--% | -.--% | 37.23x | 4.71x | 2.19x | 32.17x | 32.83x | 12.78B | ||
| 1.84% | 2.08% | 18.15x | 1.91x | 0.82x | 8.43x | 10.55x | 6.84B | ||
| 3.05% | 3.42% | 21.19x | 9.45x | 1.37x | 9.69x | 13.82x | 4.74B | ||
| 2.31% | 2.58% | 17.55x | 2.6x | 1.15x | 8.16x | 11.25x | 4.41B | ||
| 3% | 3.54% | 18.8x | 2.91x | 0.73x | 6.19x | 10.82x | 3.19B | ||
| 2.75% | 3.46% | - | - | 0.34x | 4.33x | 5.22x | 2.89B | ||
| 1.58% | 1.87% | 25.54x | 4.86x | 0.78x | 9.73x | 15.08x | 1.96B | ||
| -.--% | -.--% | -61.15x | 2.73x | 0.51x | 22.96x | -91.51x | 1.6B | ||
| 1.97% | 2.47% | 26.17x | 1.06x | 0.38x | 5.58x | 10.47x | 1.15B | ||
| 5.45% | 5.91% | 11.56x | 2.67x | 0.98x | 7.44x | 13.47x | 1.12B | ||
| 0.29% | 0.3% | 17.98x | 2.32x | - | - | - | 920M | ||
| 3.26% | 2.96% | 21.28x | 1.6x | 0.39x | 6.69x | 8.34x | 859M | ||
| -.--% | 1.74% | 24.1x | 6.99x | 0.86x | 12.58x | 19.1x | 674M | ||
| Average | 2.06% | 2.4% | 16.29x | 3.68x | 0.99x | 12.43x | 7.90x | 4.78B | |
| Weighted average by Cap. | 1.23% | 1.39% | 26.00x | 3.68x | 1.52x | 21.09x | 21.74x |
- Stock Market
- Equities
- 4164 Stock
- Sector Nahdi Medical Company
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















